In vitro evaluation of a novel ketolide antimicrobial agent, RU 64004

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 2, 1997, Pages 454-459

  Jamjian, Christine ^a   Biedenbach, Douglas J ^a   Jones, Ronald N ^a,b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN; ERYTHROMYCIN; HMR 3004; KETOLIDE; MACROLIDE; OXACILLIN; ROXITHROMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NEISSERIA; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0031053885     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.2.454     Document Type: Article

References (30)

1. Agouridas, C., Y. Beneditti, A. Bonnefoy, P. Collette, A. Denis, P. Mauvais, G. Labbe, and J. F. Chantot. 1996. Ketolides: a new class of macrolide antibacterials. Structural characteristics and biological properties ot RU 004, abstr. 14.10, p. 97. In Program and abstracts of the 3rd International Conference on the Macrolides, Azalides, and Streptogramins.
2. Agouridas C., A. Bonnefoy, K. Braham, P. Collette, M. Guitton, A. Hochet, P. Mauvais, and J. F. Chantot. 1995. RU 004: uptake by phagocytes, intracellular bioactivity and other immunomodulatory effects, abstr. F175, p. 143. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Agouridas, C., A. Bonnefoy, and J. F. Chantot. 1995. In vitro antibacterial activity of RU 004, a novel ketolide highly active against respiratory pathogens, abstr. F158, p. 140. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Agouridas, C., A. Bonnefoy, and J. F. Chantot. 1995. Susceptibility testing conditions used and antibacterial activity of RU 004, abstr. F169, p. 142. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Agouridas, C., A. Bonnefoy, and J. F. Chantot. 1995. In vivo antibacterial activity of RU 004, a novel ketolide highly active against respiratory pathogens, abstr. F171, p. 143. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. Agouridas, C., P. Collette, P. Mauvais, and J. F. Chantot 1995. RU 004: preliminary studies on the mechanism of action, abstr. F170, p. 142. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Bornstein, N., H. Behr, Y. Burn, and J. Fleurette. 1995. In vitro activity of RU 004 on Legionella species, abstr. F166, p. 142. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotheraphy, American Society for Microbiology, Washington, D.C.
8. Bouchard, S., H. P. Doermann, and F. Megraud. 1995. Ketolides and Helicobacter pylori: in vitro evaluation of RU 004, abstr. F163, p. 141. In Abstracts of the 35th Intersciencc Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Centers for Disease Control and Prevention. 1996. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. Morbid. Mortal. Weekly Rep. 45:1-14.
10. Cormican, M. G., and R. N. Jones. 1996. Emerging resistance to antimicrobial agents in gram-positive bacteria. Drugs 51(Suppl.):6-12.
11. Dabernat, H., M. Seguy, and C. Delmas. 1995. In vitro activity of RU 004 against Haemophilus influenzae and Moraxella catarrhalis, abstr. F161, p. 141. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
12. Ednie, L., S. Spangler, M. Jacobs, and P. Appelbaum. 1995. Antianaerobic activity of the ketolide RU 004 compared to 4 macrolides, 5 ß-lactams, clindamycin and metronidazole, abstr. F162, p. 141. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Ednie, L. M., S. K. Spangler, M. R. Jacobs, and P. C. Appelbaum. 1996. Activity of the ketolide RU 004 compared to 15 other agents against 228 erythromycin susceptible and resistant pneumococci, abstr. 3.19, p. 32. In Program and abstracts of the 3rd International Conference of the Macrolides, Azalides, and Streptogramins.
14. Fabre, R., J. D. Cavallo, J. C. Chapalain, and M. Meyran. 1995. Comparative in vitro activity of RU 004 against Neisseria gonorrhoeae and Neisseria meningitidis, abstr. F164, p. 141. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
15. Fremaux, A., G. Sissia, J. F. Chantot, and P. Geslin. 1995. Antibacterial activity of the ketolide RU 004 against multi-resistant pneumococci, abstr. F160, p. 141. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Haider, F., F. Eb, and J. Orfila. 1995. Ketolides and chlamydia: in vitro evaluation of RU 004, abstr. F165, p. 142. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
17. Jones, R. N., and M. S. Barrett. 1996. Antimicrobial activity of SCH 27899, an oligosaccharide member of the everninomycin class with a wide gram-positive spectrum. J. Clin. Microbiol. Infect. 1:1-9.
18. Jones, R. N., D. M. Johnson, and M. E. Erwin. 1996. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob. Agents Chemother. 40:720-726.
19. Labbe, G., P. Y. Abecassis, O. Courtin, M. Flor, S. Fougeat, and B. Bode. 1995. RU 004: in vitro and in vivo effects on hepatic cytochrome P-450, abstr. F174, p. 143. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Leclerq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
21. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
22. National Committee for Clinical Laboratory Standards. 1993. Methods for antimicrobial susceptibility testing of anaerobic bacteria. 3rd ed. Approved standard M11-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
23. National Committee for Clinical Laboratory Standards. 1995. Performance standards for antimicrobial susceptibility testing. 5th informational supplement, M100-S6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
24. Rajagopalan-Levasseur, P., E. Vallee, C. Agouridas, J. F. Chantot, and J. J. Pocidalo. 1995. RU 004: activity against erythromycin-resistant pneumococci and Haemophilus influenzae in murine pneumonia models, abstr. F173, p. 143. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C.
25. Renaudin, H., M. D. Aydin, and C. Bebear. 1995. Ketolides and mycoplasmas: in vitro evaluation of RU 004, abstr. F168, p. 142. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
26. Sanchez, M. L., K. K. Flint, and R. N. Jones. 1993. Occurrence of macrolidestreptogramin resistances among staphylococcal clinical isolates at a university center. Diagn. Microbiol. Infect. Dis. 16:205-213.
27. Sato, K., K. Hoshino, M. Tanaka, I. Hayakawa, and Y. Osada. 1992. Anti-microbial activity of DU-6859, a new potent fluoroquinolone against clinical isolates. Antimicrob. Agents Chemother. 36:1491-1498.
28. Tally, F. T., G. A. Ellestad, and R. T. Testa. 1995. Glycylcyclines: a new generation of tetracyclines. Antimicrob. Agents Chemother. 35:449-452.
29. Truffot-Pernot, C., N. Lounis, J. F. Chantot, and J. Grosset. 1995. In vitro activity of the ketolide RU 004 against non-tuberculous mycobacteria, abstr. F167, p. 142. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
30. Vallee, E., E. Azoulay-Dupuis, P. Rajagopalan-Levasseur, C. Agouridas, J. F. Chantot, and J. J. Pocidalo. 1995. Ketolides: screening using relevant in vivo models of erythromycin-resistant pneumococcal infection, abstr. F172, p. 143. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.